Journal of Cancer Research and Immuno-Oncology
Open Access
ISSN: 2684-1266
+44-77-2385-9429
ISSN: 2684-1266
+44-77-2385-9429
Center for Infectious Disease and Vaccinology, The Biodesign Institute, Arizona, USA
Dr. Xiaowei Liu received her Ph.D. in Biochemistry from Arizona State University in 2012. During her Ph.D. studies, she focused on DNA nanotechnology and explored the biological applications of DNA nanostructures, with an emphasis on the immunological aspect such as vaccine construction and cell-cell interactions. As a postdoctoral research associate at the Biodesign Institute, Arizona State University, her current research involves rational design and optimization of nicotine vaccine, cancer vaccines, mechanism of DNA nano-vaccines and therapeutic nanoparticles. She is an active reviewer for several reputed journals on immunology and biochemistry.
Editorial
An Overview of Doxorubicin in Cancer Therapy
Author(s): Xiaowei Liu*
DOI:
10.35248/2684-1266.21.s2.e001